MCM
MGNX icon

Manchester Capital Management’s MacroGenics MGNX Stock Holding History

Manchester Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,245
Closed -$2.09K – 1436
2025
Q3 		$2.09K Hold
1,245
– – ﹤0.01% 1071
2025
Q2 		$1.51K Hold
1,245
– – ﹤0.01% 1029
2025
Q1 		$1.58K Sell
1,245
-175
-12% -$457 ﹤0.01% 1020
2024
Q4 		$4.62K Hold
1,420
– – ﹤0.01% 903
2024
Q3 		$4.67K Hold
1,420
– – ﹤0.01% 900
2024
Q2 		$6.04K Buy
+1,420
New +$13.8K ﹤0.01% 829

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Manchester Capital Management's MGNX Position: Q4 2025 in Review

Manchester Capital Management sold out of MacroGenics (MGNX) in Q4 2025, closing a stake of 1,245 shares — an estimated $2.09K sold.

Manchester Capital Management first reported a position in MGNX in Q2 2024 and held it in 6 quarters. The position peaked at $6.04K in Q2 2024. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.

  • Manchester Capital Management reported no remaining MacroGenics position as of Q4 2025 after selling out during the quarter.
  • Manchester Capital Management sold 1,245 MacroGenics shares in Q4 2025, an estimated $2.09K.
  • Manchester Capital Management first reported a position in MacroGenics in Q2 2024 and held it in 6 quarters.
  • Manchester Capital Management's MacroGenics position peaked at $6.04K in Q2 2024.
  • 88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.

Based on Manchester Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.